Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%

201627 citationsJournal Articlegold Open Access

Authors

Ingenol mebutate gel, 0.05%, was efficacious and well tolerated for the treatment of biopsy-confirmed sBCCs on the trunk in seven patients.

Good health and well-being

Published in: Clinical Cosmetic and Investigational Dermatology

Volume Volume 9, pp. 205-209

Field-Weighted Citation Impact: 3.34